Medprin goes public at Shenzhen Stock Exchange

Medprin Regenerative Medical Technologies of Guangzhou's Huangpu district went public at the growth enterprise market at the Shenzhen Stock Exchange on July 26.

The capital raised in the initial public offering will be used to construct a headquarters base and improve the R&D of new medical equipment to increase Medprin's innovation capability and core competitiveness.

Medprin Regenerative Medical Technologies goes public at the growth enterprise market at the Shenzhen Stock Exchange on July 26.

Medprin is a high-tech enterprise that commits to the development of high-performance implantable medical equipment that relies on artificial synthetic materials and advanced manufacturing technology.

It is the only enterprise in the domestic neurosurgery sector that owns a full range of key implantable medical equipment required for craniotomy, including artificial dura mater graft, craniomaxillofacial repair products and absorbable hemostatic gauzes.

There are now 65 listed enterprises in Huangpu, and the number ranks first in Guangzhou and among national economic development zones. In addition, more than 30 local enterprises are going through registration and examination or receiving pre-listing tutoring.

Share - WeChat